BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, January 14, 2025
Home
»
Newsletters
» BioWorld MedTech
BioWorld MedTech
Nov. 20, 2015
View Archived Issues
SCS Teeming with Competition: St. Jude earns FDA nod for Proclaim, looks to gain ground within SCS market
With an FDA approval of its Proclaim elite spinal cord stimulation (SCS) system in hand, St. Jude Medical Inc. (St. Paul, Minn.) could find itself poised to take a greater share of the SCS market.
Read More
Inside the Beltway: Support for LDT discussion draft broad, but FDA wary of deadlines
Read More
Targeting the microbiome: Nutritional value of food depends critically on the gut of the eater
Read More
Domestic Products have edge: Chinese firms encouraged to pursue international investment opportunities
Read More
Old drug performing new tricks: Genentech explores new delivery for longstanding wet AMD drug
Read More
IPO floodgates open: Success of JOBS Act leading to higher IPO costs for biotechs
Read More
Agreements/contracts: AdvaMed signs strategic cooperation accord with China
Read More
Financings: Fractyl extends series C, for round total of $57M
Read More
Product briefs
Read More
Briefly Noted
Read More
MDD's Diagnostics Extra
Read More
